gemfibrozil and valerates

gemfibrozil has been researched along with valerates in 67 studies

Research

Studies (67)

Timeframe	Studies, this research(%)	All Research%
pre-1990	67 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Konttinen, A; Kuisma, I; Ojala, K; Pohjola, S; Ralli, R	1
Arellano, F; de Cos, MA; Quirós, C; Valiente, R	1
Cramb, R; Hughes, EA; Jones, AF	1
Krause, BR; Newton, RS	3
Hindmarsh, JT; Meuffels, M; Nair, R; Ooi, TC; Simo, IE; Sorisky, A	1
Elias, PM; Fisher, DA; LeBoit, PL	1
Houlston, R; Lewis, B; Quiney, J; Watts, GF	1
Grundy, SM	1
Elo, MO; Frick, MH; Haapa, K; Heinonen, OP; Heinsalmi, P; Helo, P; Huttunen, JK; Kaitaniemi, P; Koskinen, P; Manninen, V	1
Dodge, HT; Kostis, JB; Kuo, PT; Moreyra, AB; Wilson, AC	1
Bell, H; Dittmeier, G; Martinez, L	1
Koskinen, P; Lassila, R; Laustiola, K; Manninen, V; Pellinen, T	1
Bilheimer, DW; East, C; Grundy, SM	1
Elo, O; Frick, MH; Haapa, K; Heinonen, OP; Heinsalmi, P; Helo, P; Huttunen, JK; Kaitaniemi, P; Koskinen, P; Manninen, V	1
Rifkind, BM	1
Elo, O; Frick, MH; Haapa, K; Heinonen, OP; Heinsalmi, P; Helo, P; Huttunen, JK; Kaitaniemi, P; Koskinen, P; Mänttäri, M	1
Heinonen, OP; Javela, K; Mäenpää, H; Mälkönen, M; Manninen, V; Pikkarainen, J	1
Heinonen, OP; Mäenpää, H; Manninen, V	1
Idzior-Waluś, B; Jamska, B; Malczewska-Malec, M; Nowacki, G; Sznajd, J	1
Idzior-Waluś, B; Iwanejko, J; Malczewska-Malec, M; Nowacki, G; Sznajd, J	1
Augustin, J; Gnasso, A; Haberbosch, W; Lehner, B; Leiss, O; von Bergmann, K	1
Koskinen, P; Kovanen, PT; Manninen, V	1
Harvengt, C	1
Chang, DM; Fuh, MM; Jeng, CY; Shian, LR	1
Barre, J; Hamberger, C; Houin, G; Taiclet, A; Tillement, JP; Zini, R	1
Kinkel, AW; Parker, TD; Randinitis, EJ	1
Breslow, JL; Eisenberg, S; Weintraub, MS	1
Deans, K; Hartshorn, JC	1
de la Iglesia, FA; Fitzgerald, JE; Petrere, JA	1
Colli, S; Franceschini, G; Gianfranceschi, G; Maderna, P; Montanari, G; Sirtori, CR; Sirtori, M; Tremoli, E; Zoppi, F	1
Chaplin, L; Cutler, RE; Forland, SC	1
Cutler, RE; Evans, JR; Forland, SC	1
Chen, JJ; Chou, TY; Han, HK; Ho, LT; Li, SH; Liu, YF; Perng, JC	1
Korte, T; Kuusi, T; Pasternack, A; Solakivi, T; Vänttinen, T	1
Augustin, J; Gnasso, A; Leiss, O; von Bergmann, K	1
Grundy, SM; Vega, GL	1
Hengy, H; Kölle, EU	1
Manninen, V	2
Gartside, PS; Hynd, BA; Kashyap, ML; Saku, K	1
Kaukola, S; Mälkönen, M; Manninen, V; Torstila, I; Virtamo, J	1
Pickering, JE	2
Grundy, SM; Kesäniemi, YA	1
Nash, DT	3
Samuel, P	1
Glueck, C	1
Maxwell, RE; Nawrocki, JW; Uhlendorf, PD	1
Kinkel, AW; Nelson, C; Parker, TD; Randinitis, EJ	1
Chin, B; Deutsch, S; Fenderson, RW; Menachemi, E; Samuel, P	1
Eisalo, A; Kuusisto, P; Mälkönen, M; Manninen, V; Tuomilehto, J; Virtamo, J	1
Buchanan, RA; De La Iglesia, FA; Lewis, JE; Marcus, EL; McMahon, G	1
Hoefle, M; Maxwell, RE; Sircar, I	1
Nye, ER; Sutherland, WH; Temple, Wa	1
Hall, MJ; Howard, AN; Nelson, LM; Russell, RI	1
Adams, CM; Etherington, MD; Goodland, FC; Middleton, JE; O'Brien, JR; Shuttleworth, RD	1
Lewis, JE	1
Berg, K; Børresen, AL; Dahlén, G; Ericson, C; Gillnäs, T	2
de la Iglesia, FA; Fitzgerald, JE; Lake, RS; McGuire, EJ; Sanyer, JL; Schardein, JL	1

Trials

30 trial(s) available for gemfibrozil and valerates

Article	Year
The effect of gemfibrozil on serum lipids in diabetic patients. Annals of clinical research, 1979, Volume: 11, Issue:6 Topics: Administration, Oral; Adult; Aged; Blood Glucose; Cholesterol; Clinical Trials as Topic; Diabetes Mellitus; Eye; Female; Gemfibrozil; Humans; Hypoglycemic Agents; Insulin; Lipids; Lipoproteins; Male; Middle Aged; Pentanoic Acids; Triglycerides; Valerates; Xylenes	1979
Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA, 1988, Aug-05, Volume: 260, Issue:5 Topics: Adult; Coronary Disease; Double-Blind Method; Finland; Gemfibrozil; Humans; Hypolipidemic Agents; Lipids; Male; Middle Aged; Myocardial Infarction; Pentanoic Acids; Random Allocation; Risk Factors; Valerates	1988
Gemfibrozil therapy in patients with coronary heart disease. Missouri medicine, 1988, Volume: 85, Issue:1 Topics: Adult; Cholesterol, HDL; Clinical Trials as Topic; Coronary Disease; Female; Gemfibrozil; Humans; Hypolipidemic Agents; Male; Middle Aged; Pentanoic Acids; Valerates	1988
Gemfibrozil decreases platelet reactivity in patients with hypercholesterolemia during physical stress. Clinical pharmacology and therapeutics, 1988, Volume: 43, Issue:3 Topics: Adult; Blood Platelets; Clinical Trials as Topic; Gemfibrozil; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Pentanoic Acids; Physical Exertion; Platelet Aggregation; Thromboxane B2; Valerates	1988
Combination drug therapy for familial combined hyperlipidemia. Annals of internal medicine, 1988, Jul-01, Volume: 109, Issue:1 Topics: Adult; Cholelithiasis; Colestipol; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Pentanoic Acids; Polyamines; Random Allocation; Ultrasonography; Valerates	1988
Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. The New England journal of medicine, 1987, Nov-12, Volume: 317, Issue:20 Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Finland; Gemfibrozil; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Pentanoic Acids; Random Allocation; Risk Factors; Triglycerides; Valerates	1987
Gemfibrozil, lipids, and coronary risk. The New England journal of medicine, 1987, Nov-12, Volume: 317, Issue:20 Topics: Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Gemfibrozil; Humans; Hypolipidemic Agents; Male; Middle Aged; Pentanoic Acids; Random Allocation; Valerates	1987
The Helsinki Heart Study: basic design and randomization procedure. European heart journal, 1987, Volume: 8 Suppl I Topics: Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Finland; Gemfibrozil; Humans; Hypolipidemic Agents; Male; Middle Aged; Pentanoic Acids; Random Allocation; Valerates	1987
Minimal doses of digoxin: a new marker for compliance to medication. European heart journal, 1987, Volume: 8 Suppl I Topics: Clinical Trials as Topic; Coronary Disease; Creatinine; Digoxin; Double-Blind Method; Finland; Follow-Up Studies; Gemfibrozil; Humans; Hypolipidemic Agents; Male; Middle Aged; Patient Compliance; Pentanoic Acids; Random Allocation; Valerates	1987
Comparison of the digoxin marker with capsule counting and compliance questionnaire methods for measuring compliance to medication in a clinical trial. European heart journal, 1987, Volume: 8 Suppl I Topics: Capsules; Clinical Trials as Topic; Coronary Disease; Creatinine; Digoxin; Double-Blind Method; Finland; Follow-Up Studies; Gemfibrozil; Humans; Hypolipidemic Agents; Male; Middle Aged; Patient Compliance; Pentanoic Acids; Random Allocation; Valerates	1987
[Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. I. Changes in lipid levels after treatment (the "net" reduction)]. Przeglad lekarski, 1987, Volume: 44, Issue:12 Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Double-Blind Method; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Male; Middle Aged; Pentanoic Acids; Triglycerides; Valerates	1987
[Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. II. Relation between the results of treatment and type of dyslipoproteinemia]. Przeglad lekarski, 1987, Volume: 44, Issue:12 Topics: Apolipoproteins; Cholesterol; Clinical Trials as Topic; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Pentanoic Acids; Triglycerides; Valerates	1987
A comparison of different formulations and dosage administrations of gemfibrozil. The American journal of cardiology, 1986, May-30, Volume: 57, Issue:14 Topics: Administration, Oral; Adult; Apolipoproteins; Cholesterol, HDL; Cholesterol, LDL; Drug Administration Schedule; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Middle Aged; Pentanoic Acids; Tablets; Time Factors; Valerates	1986
Normalization of lipoprotein lipase and hepatic lipase by gemfibrozil results in correction of lipoprotein abnormalities in chronic renal failure. Clinical nephrology, 1987, Volume: 27, Issue:4 Topics: Adult; Aged; Clinical Trials as Topic; Enzyme Activation; Female; Gemfibrozil; Humans; Kidney Failure, Chronic; Lipase; Lipoprotein Lipase; Lipoproteins; Liver; Male; Middle Aged; Pentanoic Acids; Triglycerides; Valerates	1987
Gemfibrozil therapy in primary hypertriglyceridemia associated with coronary heart disease. Effects on metabolism of low-density lipoproteins. JAMA, 1985, Apr-26, Volume: 253, Issue:16 Topics: Adult; Aged; Apolipoproteins B; Cholesterol, LDL; Coronary Disease; Gemfibrozil; Humans; Hyperlipidemias; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Pentanoic Acids; Triglycerides; Valerates	1985
The Gemfibrozil Study. Acta medica Scandinavica. Supplementum, 1985, Volume: 701 Topics: Adult; Clinical Trials as Topic; Coronary Disease; Female; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Pentanoic Acids; Valerates	1985
Plasma prekallikrein, kallikrein inhibitors, kininogen and lipids during gemfibrozil treatment in type II dyslipidaemia. Acta medica Scandinavica. Supplementum, 1982, Volume: 668 Topics: Adult; Aprotinin; Body Weight; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Kallikreins; Kininogens; Lipids; Lipoproteins, HDL; Male; Middle Aged; Pentanoic Acids; Prekallikrein; Triglycerides; Valerates	1982
Clinical results with gemfibrozil and background to the Helsinki Heart Study. The American journal of cardiology, 1983, Aug-22, Volume: 52, Issue:4 Topics: Adult; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Double-Blind Method; Follow-Up Studies; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipoproteins, HDL; Male; Middle Aged; Pentanoic Acids; Triglycerides; Valerates	1983
Clinical results with gemfibrozil. The American journal of cardiology, 1983, Aug-22, Volume: 52, Issue:4 Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Gemfibrozil; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Pentanoic Acids; Triglycerides; Valerates	1983
Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man. JAMA, 1984, May-04, Volume: 251, Issue:17 Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Clofibrate; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Pentanoic Acids; Steroids; Triglycerides; Valerates	1984
Influence of gemfibrozil on high-density lipoproteins. The American journal of cardiology, 1983, Aug-22, Volume: 52, Issue:4 Topics: Animals; Cholesterol; Cholesterol, HDL; Gemfibrozil; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Pentanoic Acids; Rats; Valerates	1983
Effect of gemfibrozil on serum lipids in man. Angiology, 1982, Volume: 33, Issue:9 Topics: Adult; Aged; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Clinical Trials as Topic; Double-Blind Method; Female; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Pentanoic Acids; Valerates	1982
Gemfibrozil in the treatment of dyslipidaemia. A 5-year follow-up study. Acta medica Scandinavica. Supplementum, 1982, Volume: 668 Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Clinical Trials as Topic; Follow-Up Studies; Gemfibrozil; Humans; Hypolipidemic Agents; Lipid Metabolism; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Myocardial Infarction; Pentanoic Acids; Valerates	1982
The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate. The New Zealand medical journal, 1980, Nov-12, Volume: 92, Issue:671 Topics: Adult; Aged; Cholesterol; Clofibrate; Female; Gemfibrozil; Humans; Hyperlipoproteinemias; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Pentanoic Acids; Placebos; Triglycerides; Valerates; Xylenes	1980
Gemfibrozil--the effect of biliary cholesterol saturation of a new lipid-lowering agent and its comparison with clofibrate. Atherosclerosis, 1981, Volume: 39, Issue:4 Topics: Bile; Cholesterol; Clofibrate; Gemfibrozil; Humans; Hypolipidemic Agents; Lipids; Male; Pentanoic Acids; Valerates; Xylenes	1981
A pilot study of the effect of Gemfibrozil on some haematological parameters. Thrombosis research, 1982, May-15, Volume: 26, Issue:4 Topics: Aged; Arteriosclerosis; Blood Coagulation Tests; Cholesterol; Cholesterol, HDL; Female; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins, HDL; Male; Middle Aged; Pentanoic Acids; Triglycerides; Valerates	1982
Hyperlipoproteinemia, atherosclerosis and gemfibrozil. Angiology, 1982, Volume: 33, Issue:9 Topics: Adult; Aged; Arteriosclerosis; Cholesterol; Female; Gemfibrozil; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Pentanoic Acids; Triglycerides; Valerates	1982
Long-term use of gemfibrozil (Lopid) in the treatment of dyslipidemia. Angiology, 1982, Volume: 33, Issue:9 Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Pentanoic Acids; Triglycerides; Valerates	1982
Effect of gemfibrozil on serum lipid levels. Artery, 1980, Volume: 7, Issue:3 Topics: Cholesterol; Clinical Trials as Topic; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Middle Aged; Pentanoic Acids; Triglycerides; Valerates; Xylenes	1980
The effect of Gemfibrozil on human serum apolipoproteins and on serum reserve cholesterol binding capacity (SRCBC). Artery, 1981, Volume: 9, Issue:1 Topics: Apolipoproteins; Cholesterol; Clinical Trials as Topic; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins, HDL; Male; Middle Aged; Pentanoic Acids; Valerates; Xylenes	1981

Other Studies

37 other study(ies) available for gemfibrozil and valerates

Article	Year
Gemfibrozil-induced headache. Lancet (London, England), 1988, Mar-26, Volume: 1, Issue:8587 Topics: Female; Gemfibrozil; Headache; Humans; Hypolipidemic Agents; Middle Aged; Pentanoic Acids; Valerates	1988
Gemfibrozil plus cholestyramine in familial hypercholesterolaemia. Lancet (London, England), 1988, Apr-02, Volume: 1, Issue:8588 Topics: Adult; Cholesterol; Cholestyramine Resin; Drug Evaluation; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Middle Aged; Pentanoic Acids; Valerates	1988
Gemfibrozil increases both apo A-I and apo E concentrations. Comparison to other lipid regulators in cholesterol-fed rats. Atherosclerosis, 1986, Volume: 59, Issue:1 Topics: Animals; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins E; Bezafibrate; Cholesterol, Dietary; Cholesterol, HDL; Clofibrate; Clofibric Acid; Fenofibrate; Fibric Acids; Gemfibrozil; Male; Pentanoic Acids; Rats; Rats, Inbred Strains; Valerates	1986
Change in composition of high density lipoprotein during gemfibrozil therapy. Atherosclerosis, 1987, Volume: 67, Issue:2-3 Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Cholesterol, HDL; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins, HDL; Male; Middle Aged; Pentanoic Acids; Phospholipids; Triglycerides; Valerates	1987
Gemfibrozil and coronary heart disease. The New England journal of medicine, 1988, May-12, Volume: 318, Issue:19 Topics: Accidents; Adult; Coronary Disease; Gemfibrozil; Humans; Hypolipidemic Agents; Male; Middle Aged; Pentanoic Acids; Valerates; Violence	1988
Exacerbation of psoriasis by the hypolipidemic agent, gemfibrozil. Archives of dermatology, 1988, Volume: 124, Issue:6 Topics: Female; Gemfibrozil; Humans; Hypolipidemic Agents; Middle Aged; Pentanoic Acids; Psoriasis; Valerates	1988
Gemfibrozil in the treatment of resistant familial hypercholesterolaemia and type III hyperlipoproteinaemia. Journal of the Royal Society of Medicine, 1988, Volume: 81, Issue:5 Topics: Cholesterol; Cholesterol, HDL; Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hypolipidemic Agents; Male; Pentanoic Acids; Triglycerides; Valerates	1988
Lessons from the Helsinki Heart Study. Fibric acid therapy for dyslipidemia. Postgraduate medicine, 1988, Volume: 84, Issue:1 Topics: Adult; Bile Acids and Salts; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Gemfibrozil; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Pentanoic Acids; Triglycerides; Valerates	1988
Treatment of type III hyperlipoproteinemia with gemfibrozil to retard progression of coronary artery disease. American heart journal, 1988, Volume: 116, Issue:1 Pt 1 Topics: Adult; Combined Modality Therapy; Coronary Disease; Drug Evaluation; Exercise Test; Female; Gemfibrozil; Hand Dermatoses; Humans; Hyperlipoproteinemia Type III; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Middle Aged; Pentanoic Acids; Valerates; Xanthomatosis	1988
Effect of gemfibrozil on lipids, apoproteins, and postheparin lipolytic activities in normolipidemic subjects. Metabolism: clinical and experimental, 1986, Volume: 35, Issue:5 Topics: Adult; Apolipoproteins; Cholesterol; Fat Emulsions, Intravenous; Gemfibrozil; Heparin; Humans; Hypolipidemic Agents; Lipids; Lipolysis; Lipoproteins, HDL; Lipoproteins, VLDL; Male; Pentanoic Acids; Phospholipids; Triglycerides; Valerates	1986
Drugs recently released in Belgium: mitoxantrone, gemfibrozil. Acta clinica Belgica, 1986, Volume: 41, Issue:2 Topics: Anthraquinones; Antineoplastic Agents; Gemfibrozil; Humans; Hypolipidemic Agents; Mitoxantrone; Pentanoic Acids; Valerates	1986
The hypolipidemic effect of gemfibrozil on hyperlipidemia in patients with non-insulin-dependent diabetes mellitus. Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association, 1986, Volume: 85, Issue:5 Topics: Aged; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Middle Aged; Pentanoic Acids; Valerates	1986
Gemfibrozil treatment and the relationship between HDL cholesterol and apoE distribution in cholesterol-fed rats. Atherosclerosis, 1986, Volume: 61, Issue:3 Topics: Animals; Apolipoproteins B; Apolipoproteins E; Cholesterol, Dietary; Cholesterol, HDL; Diet; Gemfibrozil; Hypercholesterolemia; Hypothyroidism; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Pentanoic Acids; Rats; Rats, Inbred Strains; Triglycerides; Valerates	1986
In vitro binding study of gemfibrozil to human serum proteins and erythrocytes: interactions with other drugs. International journal of clinical pharmacology research, 1986, Volume: 6, Issue:6 Topics: Blood Proteins; Erythrocytes; Gemfibrozil; Humans; Mathematics; Pentanoic Acids; Serum Albumin; Valerates	1986
Liquid chromatographic determination of gemfibrozil and its metabolite in plasma. Journal of chromatography, 1986, Dec-19, Volume: 383, Issue:2 Topics: Biotransformation; Chromatography, Liquid; Gemfibrozil; Humans; Kinetics; Pentanoic Acids; Valerates	1986
Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil. The Journal of clinical investigation, 1987, Volume: 79, Issue:4 Topics: Cholestyramine Resin; Chylomicrons; Dietary Fats; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Lipoproteins; Male; Pentanoic Acids; Triglycerides; Valerates; Vitamin A	1987
Treatment of hyperlipidemia with gemfibrozil. The Journal of cardiovascular nursing, 1987, Volume: 1, Issue:4 Topics: Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Pentanoic Acids; Valerates	1987
Experimental studies on reproduction with the lipid-regulating agent gemfibrozil. Fundamental and applied toxicology : official journal of the Society of Toxicology, 1987, Volume: 8, Issue:4 Topics: Animals; Body Weight; Eating; Female; Fertility; Fetus; Gemfibrozil; Hypolipidemic Agents; Male; Pentanoic Acids; Pregnancy; Rats; Reproduction; Species Specificity; Teratogens; Valerates	1987
Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemia. The Journal of laboratory and clinical medicine, 1987, Volume: 110, Issue:3 Topics: Adult; Aged; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, VLDL; Female; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Lipoproteins, VLDL; Male; Middle Aged; Pentanoic Acids; Platelet Aggregation; Triglycerides; Valerates	1987
Assay of gemfibrozil in plasma by "high-performance" liquid chromatography. Clinical chemistry, 1987, Volume: 33, Issue:10 Topics: Chromatography, High Pressure Liquid; Gemfibrozil; Humans; Pentanoic Acids; Valerates	1987
The effect of renal function on the pharmacokinetics of gemfibrozil. Journal of clinical pharmacology, 1987, Volume: 27, Issue:12 Topics: Aged; Gemfibrozil; Half-Life; Humans; Hypolipidemic Agents; Kidney Diseases; Male; Middle Aged; Pentanoic Acids; Valerates	1987
Gemfibrozil has antilipemic effects on diabetic patients with hyperlipidemia. Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1987, Volume: 39, Issue:1 Topics: Adult; Aged; Diabetes Mellitus, Type 2; Drug Evaluation; Female; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Pentanoic Acids; Valerates	1987
Effect of gemfibrozil on biliary lipid metabolism in normolipemic subjects. Metabolism: clinical and experimental, 1985, Volume: 34, Issue:1 Topics: Adult; Bile; Bile Acids and Salts; Biliary Tract; Body Weight; Cholesterol; Cholesterol, HDL; Duodenum; Eating; Gallbladder; Gemfibrozil; Humans; Hypolipidemic Agents; Lipid Metabolism; Liver; Male; Pentanoic Acids; Triglycerides; Valerates	1985
Apolipoprotein changes associated with the plasma lipid-regulating activity of gemfibrozil in cholesterol-fed rats. Journal of lipid research, 1985, Volume: 26, Issue:8 Topics: Animals; Apolipoproteins; Apolipoproteins A; Apolipoproteins E; Cholesterol, HDL; Cholesterol, LDL; Dietary Fats; Gemfibrozil; Hypolipidemic Agents; Lipids; Lipoproteins; Lipoproteins, IDL; Lipoproteins, VLDL; Male; Pentanoic Acids; Rats; Rats, Inbred Strains; Valerates	1985
Determination of gemfibrozil in plasma by high performance liquid chromatography. Arzneimittel-Forschung, 1985, Volume: 35, Issue:11 Topics: Chromatography, High Pressure Liquid; Gemfibrozil; Humans; Hypolipidemic Agents; Ibuprofen; Indicators and Reagents; Pentanoic Acids; Time Factors; Valerates	1985
Mechanism of action of gemfibrozil on lipoprotein metabolism. The Journal of clinical investigation, 1985, Volume: 75, Issue:5 Topics: Apolipoprotein A-I; Apolipoprotein A-II; Apolipoprotein C-II; Apolipoprotein C-III; Apolipoproteins A; Apolipoproteins C; Gemfibrozil; Humans; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Kinetics; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Particle Size; Pentanoic Acids; Triglycerides; Valerates	1985
Gemfibrozil in combination with other drugs for severe hyperlipidemia. Preliminary study comprising four cases. Postgraduate medicine, 1983, Volume: 73, Issue:4 Topics: Adult; Cholesterol; Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hyperlipidemias; Lipoproteins, HDL; Male; Middle Aged; Niacin; Pentanoic Acids; Probucol; Triglycerides; Valerates	1983
Effects of gemfibrozil on serum lipids. The American journal of medicine, 1983, May-23, Volume: 74, Issue:5A Topics: Adult; Aged; Double-Blind Method; Drug Evaluation; Female; Gemfibrozil; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipids; Male; Middle Aged; Pentanoic Acids; Valerates	1983
Some comparative effects of gemfibrozil, clofibrate, bezafibrate, cholestyramine and compactin on sterol metabolism in rats. Atherosclerosis, 1983, Volume: 48, Issue:3 Topics: Animals; Anticholesteremic Agents; Bezafibrate; Caprylates; Carbon Radioisotopes; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Gemfibrozil; Hypolipidemic Agents; Liver; Lovastatin; Male; Mevalonic Acid; Naphthalenes; Pentanoic Acids; Rats; Rats, Inbred F344; Sterols; Valerates	1983
Gas chromatographic determination of gemfibrozil and its metabolites in plasma and urine. Journal of chromatography, 1984, Apr-13, Volume: 307, Issue:1 Topics: Administration, Oral; Biological Availability; Chromatography, Gas; Gemfibrozil; Humans; Hypolipidemic Agents; Kinetics; Pentanoic Acids; Valerates	1984
Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment. Atherosclerosis, 1982, Volume: 43, Issue:1 Topics: Gemfibrozil; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Liver; Long-Term Care; Microscopy, Electron; Pentanoic Acids; Valerates	1982
Phenylenebis(oxy)bis[2,2-dimethylpentanoic acid]s: agents that elevate high-density lipoproteins. Journal of medicinal chemistry, 1983, Volume: 26, Issue:7 Topics: Animals; Biological Assay; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Gemfibrozil; Hypolipidemic Agents; Indicators and Reagents; Lipoproteins, HDL; Lipoproteins, LDL; Male; Pentanoic Acids; Rats; Structure-Activity Relationship; Valerates	1983
Gemfibrozil--a new lipid lowering agent. Journal of medicine, 1980, Volume: 11, Issue:2-3 Topics: Cholesterol; Clofibrate; Dose-Response Relationship, Drug; Double-Blind Method; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Pentanoic Acids; Triglycerides; Valerates; Xylenes	1980
New lipid-lowering drug now on the market. JAMA, 1982, Mar-19, Volume: 247, Issue:11 Topics: Gemfibrozil; Humans; Lipids; Pentanoic Acids; Valerates; Xylenes	1982
Gemfibrozil for hyperlipidemia. The Medical letter on drugs and therapeutics, 1982, Jun-25, Volume: 24, Issue:612 Topics: Cholesterol; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Pentanoic Acids; Triglycerides; Valerates	1982
Nutritional & pharmacologic management of hyperlipoproteinemia. Angiology, 1982, Volume: 33, Issue:9 Topics: Cholesterol; Cholesterol, Dietary; Clofibrate; Dietary Fats; Gemfibrozil; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, VLDL; Pentanoic Acids; Valerates	1982
Carcinogen bioassay and mutagenicity studies with the hypolipidemic agent gemfibrozil. Journal of the National Cancer Institute, 1981, Volume: 67, Issue:5 Topics: Animals; Biotransformation; Body Weight; Carcinogens; Female; Gemfibrozil; Hypolipidemic Agents; Liver; Liver Neoplasms, Experimental; Male; Mice; Mutagenicity Tests; Mutagens; Neoplasms, Experimental; Pentanoic Acids; Rats; Salmonella typhimurium; Valerates; Xylenes	1981